ATLASGilead Sciences (GILD) Q3 2026 earnings results
Gilead Sciences (GILD) reported EPS of $2.55 against an analyst estimate of $2.17: a beat of $0.38 (17.5%). The quarter ended Sep 30, 2026; the company reported on Thursday, October 29, 2026, after the close.
Status: Confirmed · cross-checked Nov 2 · Source: EODHD (calendar and fundamentals, cross-checked)
Notify me when Gilead Sciences reports
Track GILD free Add Gilead Sciences to a free ATLAS watchlist.
GILD Q3 2026 results at a glance
| EPS reported | $2.55 |
|---|---|
| EPS estimate | $2.17 |
| Surprise | Beat · +$0.38 (+17.5%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Oct 29, 2026, after the close |
| Status | Confirmed · cross-checked Nov 2 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is Gilead Sciences’s Q3 2026, a calendar-year company.
Gilead Sciences EPS surprise history: last 5 quarters
Gilead Sciences beat the EPS estimate in 5 of its last 5 reports, with an average surprise of +9.8%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 29, 2026 | $2.17 | $2.55 | +17.5% | Beat | – |
| Aug 4, 2026 | -$7.25 | -$6.75 | +6.9% | Beat | +0.5% |
| May 7, 2026 | $1.91 | $2.03 | +6.3% | Beat | -3.7% |
| Feb 10, 2026 | $1.81 | $1.86 | +2.8% | Beat | +2.7% |
| Oct 30, 2025 | $2.14 | $2.47 | +15.4% | Beat | +1.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
GILD stock reaction to the report
GILD moved +3.06% in the first session that reflects the report (close of Oct 29, 2026 $165.61 to close of Oct 30, 2026 $170.68). Since the report: +2.85% (latest close $170.33 on Nov 2, 2026, against $165.61 before the reaction).
Next GILD earnings report
Gilead Sciences has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the GILD earnings calendar.
ATLAS fair value and signal for GILD
| Last price | $170.33 (-0.2%) |
|---|---|
| ATLAS fair value | $177.75 (range $140.51–$224.86) · price is 4% below it |
| Chance of a higher close in 1 month | 51% (normal range $162.52–$179.38) |
These are model outputs from the same valuation and calibrated model as the Gilead Sciences stock page. They describe an ordinary period and are not a forecast of any particular outcome.
Gilead Sciences Q3 2026 earnings: frequently asked questions
Did Gilead Sciences beat earnings estimates for Q3 2026?
Gilead Sciences reported EPS of $2.55 against an analyst estimate of $2.17: a beat of $0.38 (17.5%).
When did Gilead Sciences report Q3 2026 results?
Gilead Sciences reported on Thursday, October 29, 2026, after the close, for the quarter ended Wednesday, September 30, 2026.
How often does GILD beat EPS estimates?
In its last 5 reports with a recorded result, Gilead Sciences beat the EPS estimate 5 times; the average surprise was +9.8%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer